Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ACADIA Pharmaceuticals Inc. (ACAD) had Weighted-Average Shares Outstanding (Diluted) of 168.68M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$264.57M |
|
$26.67M |
|
$20.73M |
|
$243.83M |
|
$232.19M |
|
$32.37M |
|
$7.84M |
|
$40.21M |
|
$40.21M |
|
$26.67M |
|
$26.67M |
|
$26.67M |
|
$26.67M |
|
$32.37M |
|
$33.77M |
|
167.83M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
168.68M |
$0.16 |
|
$0.16 |
|
| Balance Sheet Financials | |
$960.55M |
|
$3.55M |
|
$265.00M |
|
$1.23B |
|
$330.02M |
|
-- |
|
$73.15M |
|
$403.17M |
|
$822.38M |
|
$708.04M |
|
$822.38M |
|
168.61M |
|
| Cash Flow Statement Financials | |
$84.28M |
|
$-167.34M |
|
$17.79M |
|
$328.36M |
|
$263.11M |
|
$-65.25M |
|
$25.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
92.16% |
|
12.24% |
|
12.24% |
|
-- |
|
15.20% |
|
10.08% |
|
$83.98M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.79 |
|
2.21 |
|
40.71 |
|
3.24% |
|
3.77% |
|
2.18% |
|
3.24% |
|
$4.88 |
|
$0.50 |
|
$0.50 |
|